How well maxillofacial prosthetics help chewing and daily life after upper throat cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a follow-up study of patients with a history of upper aerodigestive tract cancer who receive maxillofacial prosthetic rehabilitation. Participants undergo clinical exams and functional tests, plus questionnaires, before rehabilitation and at three months and one year after rehabilitation. Assessments cover oral health, tongue movement, salivary flow, chewing performance, and oral-related quality of life. The study is conducted at Estaing University Hospital in Clermont-Ferrand and involves coordinated visits to capture changes over time. Interventions consist of prosthetic oral rehabilitation to restore function and appearance.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patient who has given their consent
* Patient with a history of upper aerodigestive tract cancer
* Cooperative patient
* Patient affiliated with a Social Security scheme
* Patient capable of understanding and participating in the study
* Patient not allergic to the foods being tested

Exclusion Criteria:

* Minors
* Patients treated in the maxillofacial prosthetics clinic of the Odontology Department at Estaing University Hospital in Clermont Ferrand who do not require prosthetic rehabilitation
* Patients who are unwilling to participate in the study, particularly in attending the various follow-up sessions
* Patients who do not have a good command of written and spoken French
* Patients under guardianship, curatorship, or judicial protection
* Pregnant or breastfeeding patients
* Patients receiving enteral or parenteral nutrition
* Patients who have been diagnosed with a recurrence of their cancer and whose prognosis is life-threatening.
* Patients with cognitive impairment

Where it's running

• CHU de Clermont-Fd
  Clermont-Ferrand, France Recruiting

Study contacts

• Principal investigator: Cindy BATISSE LANCE — CHU de Clermont-Fd
• Study coordinator: Lise LACLAUTRE
• Email: promo_interne_drci@chu-clermontferrand.fr
• Phone: +334.73.754.963

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)

  This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.

  Recruiting Phase 2 Shaukat Khanum Memorial Cancer Hospital & Research Centre · Lahore, Punjab Province · NCT07919444

• Airway ultrasound in head and neck cancer patients

  This observational study tests whether neck ultrasound measurements of the airway match CT measurements in adults with maxillofacial cancer undergoing surgery with anesthesia.

  Recruiting at 2 sites University Hospital Dubrava · Zagreb, City of Zagreb and 1 other locations · NCT07910149

• Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia

  This study tests whether metformin and naproxen can lower the chance of cancer developing in adults with Fanconi anemia.

  Recruiting at 2 sites Phase 1 Rockefeller University · Minneapolis, Minnesota and 1 other locations · NCT07901959

• Iparomlimab and Tuvonralimab With Cetuximab Before Surgery in Resectable Oral Cancer

  In this phase 2 study, patients with locally advanced, resectable oral squamous cell carcinoma will receive a combination of iparomlimab, tuvonralimab, and cetuximab before surgery to see if the treatment is safe and can shrink tumors.

  Recruiting Phase 2 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Shanghai, Shanghai Municipality · NCT07882888

• SumMET: Targeted radioligand therapy for c-MET–positive solid tumors

  This first‑in‑human study tests the safety and potential effectiveness of a radioligand therapy called [225Ac]Ac-FL-261 in adults with advanced or metastatic solid tumors that overexpress c-MET.

  Recruiting at 2 sites Phase 1/2 Full-Life Technologies UK Limited · Minneapolis, Minnesota and 1 other locations · NCT07873450

• Using Silverlon for head and neck patients with tracheostomies

  This early-phase study tests whether Silverlon dressings can prevent severe skin reactions under tracheostomy collars in adults with head and neck cancer.

  Recruiting Phase 1 State University of New York - Upstate Medical University · Syracuse, New York · NCT07856732

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.